Screening in liver disease: report of an AASLD clinical workshop (Q35762586)

10 August 2017

1 reference

title

Screening in liver disease: report of an AASLD clinical workshop (English)

1 reference

10 August 2017

0 references

1 reference

Adrian M. Di Bisceglie

5

object named as

Adrian M Di Bisceglie

1 reference

10 August 2017

8

Dawn Provenzale

1 reference

10 August 2017

Paul C Adams

1

1 reference

10 August 2017

Michael J Arthur

2

1 reference

10 August 2017

Thomas D Boyer

3

1 reference

10 August 2017

Laurie D DeLeve

4

1 reference

10 August 2017

Mark Hall

6

1 reference

10 August 2017

Theodore R Levin

7

1 reference

10 August 2017

Leonard Seeff

9

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

10 August 2017

1 reference

10 August 2017

39

1 reference

10 August 2017

5

1 reference

10 August 2017

1204-1212

1 reference

"Genetic exceptionalism" in medicine: clarifying the differences between genetic and nongenetic tests

10 August 2017

1 reference

The Daedalus effect: changes in ethical questions relating to hepatitis B virus

21 January 2018

1 reference

Uses and abuses of screening tests

21 January 2018

1 reference

7 January 2021

Genetic discrimination and health insurance: an urgent need for reform.

1 reference

7 January 2021

Laws restricting health insurers' use of genetic information: impact on genetic discrimination

1 reference

7 January 2021

Screening for hepatocellular carcinoma: survival benefit and cost-effectiveness

1 reference

7 January 2021

Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America

1 reference

7 January 2021

Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.

1 reference

7 January 2021

Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis

1 reference

7 January 2021

Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey

1 reference

7 January 2021

Screening for hemochromatosis

1 reference

7 January 2021

Natural history of the C282Y homozygote for the hemochromatosis gene (HFE) with a normal serum ferritin level.

1 reference

7 January 2021

Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria.

1 reference

7 January 2021

Population screening for haemochromatosis

1 reference

7 January 2021

Insurance, employment, and psychosocial consequences of a diagnosis of hereditary hemochromatosis in subjects without end organ damage

1 reference

7 January 2021

Psychosocial impact of C282Y mutation testing for hemochromatosis.

1 reference

7 January 2021

Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons

1 reference

7 January 2021

A population-based study of the clinical expression of the hemochromatosis gene

1 reference

7 January 2021

Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.

1 reference

7 January 2021

A European allele map of the C282Y mutation of hemochromatosis: Celtic versus Viking origin of the mutation?

1 reference

7 January 2021

Hemochromatosis and Iron Overload Screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults

1 reference

7 January 2021

Liver injury during antituberculosis treatment: an 11-year study

1 reference

7 January 2021

Hepatotoxicity due to antituberculosis therapy. Clinical profile and reintroduction of therapy

1 reference

7 January 2021

Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic

1 reference

7 January 2021

Drug-induced cholestasis

1 reference

7 January 2021

Risk management of HBsAg or anti-HCV positive healthcare workers in hospital.

1 reference

7 January 2021

Risk of hepatitis C transmission from infected medical staff to patients: model-based calculations for surgical settings

1 reference

7 January 2021

Epidemiology and prevention of hepatitis B.

1 reference

7 January 2021

Management of chronic hepatitis B.

1 reference

7 January 2021

Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease.

1 reference

7 January 2021

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

1 reference

7 January 2021

Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients

1 reference

7 January 2021

Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.

1 reference

7 January 2021

Assessment of portal hypertension in humans.

1 reference

7 January 2021

Predictors of large esophageal varices in patients with cirrhosis

1 reference

7 January 2021

Endoscopic screening for esophageal varices in cirrhosis: Is it ever cost effective?

1 reference

7 January 2021

Cost-effectiveness of screening, surveillance, and primary prophylaxis strategies for esophageal varices

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20169

1 reference

10 August 2017

1 reference